CD2 (CD2 Molecule) - Structure, Function, and Clinical Significance

A comprehensive overview of the CD2 gene, its protein product, expression patterns, associated diseases, and molecular characteristics.

Gene Information Card

Symbol CD2
Full Name CD2 molecule
Gene Type protein-coding
Chromosomal Location 1p13.1
NCBI Gene ID 914 ncbi.nlm.nih.gov/gene/914
Ensembl ID ENSG00000116824
UniProt ID P06729
OMIM ID 186990
HGNC ID 1639
Aliases T11, SRBC, LFA-2, T-cell surface antigen T11/Leu-5

Description

The CD2 gene encodes a cell adhesion molecule and transmembrane glycoprotein expressed on the surface of T cells, natural killer (NK) cells, and thymocytes. CD2 functions as a ligand for LFA-3 (CD58) and CD48, mediating cell-cell adhesion and co-stimulatory signals for T-cell activation. It plays a critical role in immune synapse formation, T-cell receptor (TCR) signaling, and NK cell cytotoxicity. CD2 is also involved in T-cell development and differentiation. Aberrant CD2 expression or function has been implicated in autoimmune diseases, immunodeficiencies, and certain hematological malignancies.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autoimmune lymphoproliferative syndrome (ALPS) CD2 mutations may impair T-cell apoptosis, leading to lymphoproliferation and autoimmunity. Case reports and functional studies; limited evidence.
T-cell acute lymphoblastic leukemia (T-ALL) CD2 is overexpressed on malignant T cells, contributing to adhesion and survival signals. Expression studies; not a direct driver mutation.
Rheumatoid arthritis (RA) CD2-mediated co-stimulation enhances autoreactive T-cell responses in synovial tissue. Association studies; CD2 as a susceptibility locus.
Type 1 diabetes (T1D) CD2 variants affect T-cell activation and immune regulation, increasing disease risk. GWAS and functional studies.
NK cell deficiency CD2 dysfunction impairs NK cell cytotoxicity, leading to recurrent infections. Rare case reports; functional assays.

Expression Profile

Tissue Expression
Tissue nTPM level
Lymph node High High
Spleen High High
Blood High High
Bone marrow Medium Medium
Thymus High High
Lung Low Low
Liver Low Low
Cell Line Expression
Cell Line nTPM Notes
Jurkat (T-cell leukemia) High T-cell line; CD2 highly expressed.
Ramos (Burkitt lymphoma) Low B-cell line; CD2 not typically expressed.
K562 (chronic myelogenous leukemia) Low Myeloid line; CD2 absent.
NK-92 (NK cell line) High NK cell line; CD2 expressed.
HUT78 (T-cell lymphoma) High T-cell line; CD2 expressed.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1Val) Missense Rare Potential loss of protein expression; functional impact unknown.
c.200C>T (p.Thr67Met) Missense Rare May affect ligand binding; not well characterized.
c.450delC (frameshift) Frameshift Very rare Predicted to cause premature truncation; likely loss-of-function.
c.600+1G>A (splice donor) Splice site Rare May disrupt splicing; functional consequence not confirmed.
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in CD2 are rare and may impair T-cell adhesion and activation, potentially leading to immunodeficiency or autoimmunity. However, no definitive pathogenic loss-of-function variants have been established in large cohorts.

Gain of Function (GOF)

No gain-of-function mutations have been reported for CD2. Overexpression in certain leukemias is likely due to transcriptional dysregulation rather than activating mutations.

Dominant Negative (DN)

No dominant-negative mutations have been described for CD2. The protein functions as a monomer; dominant-negative effects are unlikely.

Gene Ontology (GO)

• protein binding • cell adhesion molecule binding
• receptor activity • signaling receptor activity
• cell adhesion • T cell costimulation
• cell surface receptor signaling pathway • immune response
• cell-cell adhesion • positive regulation of T cell activation

Pathways

T cell receptor signaling pathway
Natural killer cell mediated cytotoxicity
Cell adhesion molecules (CAMs)
Costimulation by the CD28 family
Immune synapse formation

Protein Summary

The CD2 protein is a type I transmembrane glycoprotein of approximately 55 kDa, composed of two extracellular immunoglobulin-like domains (V and C2), a transmembrane region, and a cytoplasmic tail. The extracellular domains mediate binding to CD58 (LFA-3) in humans and CD48 in rodents. The cytoplasmic tail contains proline-rich motifs that interact with intracellular signaling molecules such as Lck, Fyn, and CD2AP, linking adhesion to T-cell activation. CD2 is heavily glycosylated and expressed on the surface of T cells, NK cells, and thymocytes. Its primary functions include promoting cell-cell adhesion, enhancing TCR-mediated signaling, and facilitating NK cell cytotoxicity. CD2 also plays a role in T-cell development and memory T-cell responses.

Related Products

Product name Cat.No. Species Gene ID
CD200 Knockout HEK293 Cell Line EDJ-KQ2099 Human 4345 Details Get a Quote
FANCD2 Knockout HEK293 Cell Line EDJ-KQ2218 Human 2177 Details Get a Quote
CD248 Knockout HEK293 Cell Line EDJ-KQ2518 Human 57124 Details Get a Quote
CD247 Knockout HEK293 Cell Line EDJ-KQ2709 Human 919 Details Get a Quote
CD2BP2 Knockout HEK293 Cell Line EDJ-KQ3435 Human 10421 Details Get a Quote
CD209 Knockout HEK293 Cell Line EDJ-KQ3776 Human 30835 Details Get a Quote
ABCD2 Knockout HEK293 Cell Line EDJ-KQ4046 Human 225 Details Get a Quote
CD2 Knockout HEK293 Cell Line EDJ-KQ4209 Human 914 Details Get a Quote
HACD2 Knockout HEK293 Cell Line EDJ-KQ4909 Human 201562 Details Get a Quote
WSCD2 Knockout HEK293 Cell Line EDJ-KQ6687 Human 9671 Details Get a Quote
C2CD2L Knockout HEK293 Cell Line EDJ-KQ6782 Human 9854 Details Get a Quote
CD226 Knockout HEK293 Cell Line EDJ-KQ7125 Human 10666 Details Get a Quote
FANCD2OS Knockout HEK293 Cell Line EDJ-KQ7533 Human 115795 Details Get a Quote
BICD2 Knockout HEK293 Cell Line EDJ-KQ7953 Human 23299 Details Get a Quote
CD2AP Knockout HEK293 Cell Line EDJ-KQ8091 Human 23607 Details Get a Quote
Displaying Records 1 To 15 Of 146 Records
Contact Us
*
*
*
*
How did you hear about us: